FDA Grants Approval to Trastuzumab Deruxtecan for HER2 Lung Cancer
Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab
Everything about lung cancer is here.
Lung cancer patients now have another treatment option. For those tumors carrying HER2 mutations, can now be treated with trastuzumab
Lung Cancer is one of the most common cancers and according to the American Cancer Society; it is by far
According to the research paper published in the Journal of the American Medical Association (JAMA) Oncology, some current and former
The researchers at Mount Sinai have found that a simple blood test called liquid biopsy could be a better indicator
Lung cancer is the third most common type of cancers in the United States, according to the Cancers for Disease
The researchers from Moffitt Cancer Center in Tampa, Florida have published results identifying the potential target for Chimeric Antigen Receptor